首页> 外文期刊>Current drug delivery >Levofloxacin and Indolicidin for Combination Antimicrobial Therapy
【24h】

Levofloxacin and Indolicidin for Combination Antimicrobial Therapy

机译:左氧氟沙星和吲哚美定用于联合抗菌治疗

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite the increasing need for antibiotics to fight infectious diseases, fewer new antibiotics are available on the market. Unfortunately, developing a new class of antibiotics is associated with high commercial risk. Therefore, modification or combination of existing antibiotics to improve their efficacy is a promising strategy. Herein, we conjugated the antibiotic, levofloxacin, with two peptides, i.e. an antimicrobial peptide indolicidin and a cell penetrating peptide (TAT). Glycolic acid and glycine linkers were used between levofloxacin and peptides. We developed an optimized condition for coupling of levofloxacin via its carboxylic group to glycolic acid using solid phase peptide synthesis (SPPS). Antibacterial and haemolytic assays were carried out on the conjugates and only the levofloxacin-indolicidin conjugate demonstrated moderate antibacterial activity. Interestingly, physical mixture of levofloxacin and indolicidin showed improvement in the activity against Gram-positive bacteria.
机译:尽管对抗击传染病的抗生素的需求不断增长,但市场上可获得的新抗生素却很少。不幸的是,开发新型抗生素与高商业风险有关。因此,对现有抗生素进行修饰或组合以提高其功效是一种有前途的策略。本文中,我们将抗生素左氧氟沙星与两种肽,即抗菌肽吲哚美定和细胞穿透肽(TAT)缀合。左氧氟沙星和肽之间使用乙醇酸和甘氨酸接头。我们开发了使用固相肽合成(SPPS)将左氧氟沙星通过其羧基与乙醇酸偶联的优化条件。在缀合物上进行了抗菌和溶血分析,只有左氧氟沙星-吲哚激肽缀合物显示出中等的抗菌活性。有趣的是,左氧氟沙星和吲哚美定的物理混合物显示出对革兰氏阳性细菌的活性有所改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号